Project
Real4Reg aims to develop, optimise, and implement artificial intelligence methods for real-world data (RWD) analyses in regulatory decision-making and health technology assessment along the product lifecycle.
Our Goals
The three overall objectives of the proposal, considering the application of real-world evidence (RWE) from real-world data (RWD) in regulatory decision-making and HTA are: to enable the use of RWD/RWE, to establish the value of RWD/RWE, to impact RWD/RWE use and analyses by providing guidance and training.
Consortium Partners
Ten consortium partners from six European countries are working on the project. They include experts from regulatory agencies/Health Technology Assessment (HTA), academia, and patient organisations, and will also be supported by a stakeholder’s advisory board.
Advisory Board
See all Advisory Board Members.